Health equity, sickle cell disease, and the thoughtful use of artificial intelligence and social media are among the key themes to be presented at the annual meeting of the American Society of Hematology.
Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.
Survival in patients who underwent the Ross procedure, a technically complex technique to replace the aortic valve, is 83% after 25 years, which matches that of the general population.